Evidence map›Paper›PMID 33970542›Full record

ArticleMicrobiologyOpen2021

Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens.

Marina Scillato, Ambra Spitale, Gino Mongelli, Grete Francesca Privitera, Katia Mangano, Antonio Cianci, Stefania Stefani, Maria Santagati

Open access · goldAbstract read
In one paragraph

Article in MicrobiologyOpen, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 1 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 1 synthesis or guideline pooled it, 132 citations in OpenAlex.

  1. Pooled it
  2. Activity ofVirulence · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Evaluation of Microbiome Therapeutic Candidates for Carbapenem-ResistantJournal of microbiology and biotechnology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Antibacterial Potential ofFoods (Basel, Switzerland) · 2026
    Article
  13. Probiotic and Postbiotic Interactions ofAntibiotics (Basel, Switzerland) · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Marina ScillatoDepartment of Biomedical and Biotechnological Sciences, Microbiology Section, University of Catania, Catania, Italy.
Ambra SpitaleDepartment of Biomedical and Biotechnological Sciences, Microbiology Section, University of Catania, Catania, Italy.
Gino MongelliDepartment of Biomedical and Biotechnological Sciences, Microbiology Section, University of Catania, Catania, Italy.
Grete Francesca PriviteraDepartment of Biomedical and Biotechnological Sciences, Microbiology Section, University of Catania, Catania, Italy.
Katia ManganoDepartment of Biomedical and Biotechnological Sciences, Oncologic, Clinical, and General Pathology Section, University of Catania, Catania, Italy.
Antonio CianciDepartment of General Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy.
Stefania StefaniDepartment of Biomedical and Biotechnological Sciences, Microbiology Section, University of Catania, Catania, Italy.
Maria SantagatiDepartment of Biomedical and Biotechnological Sciences, Microbiology Section, University of Catania, Catania, Italy.ORCID 0000-0003-1491-4973
University of Catania · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The healthy vaginal microbiota is dominated by Lactobacillus spp., which provide an important critical line of defense against pathogens, as well as giving beneficial effects to the host. We characterized L. gasseri 1A-TV, L. fermentum 18A-TV, and L. crispatus 35A-TV, from the vaginal microbiota of healthy premenopausal women, for their potential probiotic activities. The antimicrobial effects of the 3 strains and their combination against clinical urogenital bacteria were evaluated together with the activities of their metabolites produced by cell-free supernatants (CFSs). Their beneficial properties in terms of ability to interfere with vaginal pathogens (co-aggregation, adhesion to HeLa cells, biofilm formation) and antimicrobial activity mediated by CFSs were assessed against multidrug urogenital pathogens (S. agalactiae, E. coli, KPC-producing K. pneumoniae, S. aureus, E. faecium VRE, E. faecalis, P. aeruginosa, P. mirabilis, P. vulgaris, C. albicans, C. glabrata). The Lactobacilli tested exhibited an extraordinary ability to interfere and co-aggregate with urogenital pathogens, except for Candida spp., as well as to adhere to HeLa cells and to produce biofilm in the Lactobacillus combination. Lactobacillus CFSs and their combination revealed a strong bactericidal effect on the multidrug resistant indicator strains tested, except for E. faecium and E. faecalis. The antimicrobial activity was maintained after heat treatment but decreased after enzymatic treatment. All Lactobacilli showed lactic dehydrogenase activity and production of D- and L-lactic acid isomers on Lactobacillus CFSs, while only 1A-TV and 35A-TV released hydrogen peroxide and carried helveticin J and acidocin A bacteriocins. These results suggest that they can be employed as a new vaginal probiotic formulation and bio-therapeutic preparation against urogenital infections. Further, in vivo studies are needed to evaluate human health benefits in clinical situations.

Indexed as

Anti-Bacterial AgentsBacteriaDrug Resistance, Multiple, BacterialFemaleHumansLactobacillusProbioticsVaginaAnti-Bacterial Agentsantimicrobial activityLactobacilliMDR-urogenital infectionsupernatantsvaginal probiotics

Identifiers

PMID33970542
PMCPMC8483400
OpenAlexW3155789427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.